Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZK 811752 for Endometriosis
NCT00185341Phase 2Completed
- Sponsor
- Bayer
- Start
- Feb 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of BX-471 in endometriosis, sponsored by Bayer. Started Feb 2005; status: completed.
02
Drugs
BX-471
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT00185341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185341.